Ex3 Status Epilepticus Flashcards
status epilepticus
continuous seizures >/= 5minutes or consecutive, intermittent seizures w/ no signs of consciousness for >/= 5 min between each episode
refractory status epilepticus
SE that persists after standard treatment w/ at least 2 standard epileptic drugs (AED)
Cause of refractory SE
NMDA receptor upregulation (increased excitation)
GABA receptor endocytosis (increased excitation, benzo-refractory state)
More NMDA receptors you have
increased excitation
inability for brain to control excess cortical electrical activity
status epilepticus
Phase I (early phase)
initial 30 minutes of seizure activity
Phase II (Late Phase)
after 30 minutes of continuous seizure activity
types of SE
2 - convulsive SE and Non-convulsive SE
SE is associated with
Negative outcomes:
- neuro deficit
- mortality w/in first 3 months
- risk of refractory SE w/ prolonged SE
first line pharmacologic management
Lorazepam*, Midazolam
Second line pharmacologic management
Valproate, (Fos)phenytoin, phenobarbital, levetiracetam
Third line pharmacologic management (intubated)
midazolam infusion
pentobarbital infusion
propofol infusion
ketamine infusion
Third line pharmacologic management (non-intubated)
lacosamide, topiramate, valproate
MOA for management of SE
Dirty mechanism
Hit all sorts of sodium, GABA, NMDA channels
DOC First line
Lorazepam
risk of lorazepam over time
propylene glycol toxicity
propylene glycol toxicity
severe hyperosmolar gap, metabolic acidosis, hypotension, multi-organ failure
downside of using midazolam as 1st line
short acting
Lorazepam dosages SE
4mg pushes (up to 8mg)
Which Rx can have concentrations measured?
Fosphenytoin, Phenytoin
AE Fosphenytoin
hypotension, arrhythmia (rate dependent) - don’t slam it in
Dosing of Fosphenytoin
18-20 mg PE/kg IV
max 150 mg PE/min